Alzheimer's Drug Discovery Foundation
Research, , New York, United States, 11-50 Employees
Phone Number: +12*********
Who is ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Conquering Alzheimers Through Drug Discovery. Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimers Drug Discovery Foundation (ADDF) was one of the first charities to ...
Read More
-
Headquarters: New York, New York, United States
-
Date Founded: 1998
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
SIC Code: 
Does something look wrong? Fix it. | View contact records from ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Alzheimer's Drug Discovery Foundation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Alzheimer's Drug Discovery Foundation
Answer: Alzheimer's Drug Discovery Foundation's headquarters are located at New York, United States
Answer: Alzheimer's Drug Discovery Foundation's phone number is +12*********
Answer: Alzheimer's Drug Discovery Foundation's official website is https://alzdiscovery.org
Answer: Alzheimer's Drug Discovery Foundation's revenue is $25 Million to $50 Million
Answer: Alzheimer's Drug Discovery Foundation's SIC: 8733
Answer: Alzheimer's Drug Discovery Foundation's NAICS: 446110
Answer: Alzheimer's Drug Discovery Foundation has 11-50 employees
Answer: Alzheimer's Drug Discovery Foundation is in Research
Answer: Alzheimer's Drug Discovery Foundation contact info: Phone number: +12********* Website: https://alzdiscovery.org
Answer: Conquering Alzheimers Through Drug Discovery. Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimers Drug Discovery Foundation (ADDF) was one of the first charities to adopt the venture philanthropy model. Our mission is to rapidly accelerate the discovery of drugs to prevent and treat Alzheimers disease and related dementias. We are the only charity focused solely on supporting new drugs for Alzheimers. The ADDFs in-house team of six expert neuroscientists identifies and funds the most promising research initiatives around the world. They work to ensure that every viable option to prevent or treat Alzheimers is explored, and that the pipeline of drugs in development for Alzheimers is both diverse and robust. Since 1998, we have awarded over $100 million to fund more than 550 Alzheimers drug discovery programs and clinical trials in 18 countries. Today, 20% of all treatments for Alzheimers in clinical trials have received support from the ADDF.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month